Amylyx Pharmaceuticals Inc (AMLX)
2.005
-0.02
(-1.23%)
USD |
NASDAQ |
May 06, 11:16
Amylyx Pharmaceuticals Market Cap: 135.90M for May 6, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 137.60M |
| May 02, 2024 | 135.56M |
| May 01, 2024 | 130.82M |
| April 30, 2024 | 122.69M |
| April 29, 2024 | 128.79M |
| April 26, 2024 | 119.30M |
| April 25, 2024 | 120.65M |
| April 24, 2024 | 127.43M |
| April 23, 2024 | 132.18M |
| April 22, 2024 | 134.21M |
| April 19, 2024 | 126.75M |
| April 18, 2024 | 134.21M |
| April 17, 2024 | 135.56M |
| April 16, 2024 | 136.24M |
| April 15, 2024 | 140.31M |
| April 12, 2024 | 142.34M |
| April 11, 2024 | 155.22M |
| April 10, 2024 | 166.74M |
| April 09, 2024 | 180.98M |
| April 08, 2024 | 182.33M |
| April 05, 2024 | 177.59M |
| April 04, 2024 | 176.91M |
| April 03, 2024 | 178.27M |
| April 02, 2024 | 177.59M |
| April 01, 2024 | 183.69M |
| Date | Value |
|---|---|
| March 28, 2024 | 192.50M |
| March 27, 2024 | 195.21M |
| March 26, 2024 | 185.72M |
| March 25, 2024 | 183.69M |
| March 22, 2024 | 185.72M |
| March 21, 2024 | 194.53M |
| March 20, 2024 | 201.31M |
| March 19, 2024 | 198.60M |
| March 18, 2024 | 193.86M |
| March 15, 2024 | 219.61M |
| March 14, 2024 | 214.87M |
| March 13, 2024 | 233.17M |
| March 12, 2024 | 233.17M |
| March 11, 2024 | 257.57M |
| March 08, 2024 | 227.75M |
| March 07, 2024 | 1.286B |
| March 06, 2024 | 1.291B |
| March 05, 2024 | 1.278B |
| March 04, 2024 | 1.297B |
| March 01, 2024 | 1.268B |
| February 29, 2024 | 1.278B |
| February 28, 2024 | 1.326B |
| February 27, 2024 | 1.288B |
| February 26, 2024 | 1.190B |
| February 23, 2024 | 1.196B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
119.30M
Minimum
Apr 26 2024
2.722B
Maximum
Jan 27 2023
1.404B
Average
1.380B
Median
Market Cap Benchmarks
| Cassava Sciences Inc | 950.09M |
| iRhythm Technologies Inc | 3.277B |
| Bristol-Myers Squibb Co | 89.11B |
| Moderna Inc | 45.55B |
| ACADIA Pharmaceuticals Inc | 2.855B |
Market Cap Related Metrics
| PE Ratio | 2.864 |
| PS Ratio | 0.3689 |
| Price to Book Value | 0.3136 |
| Price to Free Cash Flow | 13.16 |
| Price | 2.005 |
| Earnings Yield | 34.91% |
| Operating PE Ratio | 3.621 |
| Normalized PE Ratio | 2.864 |